Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Oncology|February 6, 2024
Prognostic Value of the Geriatric Nutritional Risk Index in Previously Untreated Patients with Advanced Non-Small Cell Lung Cancer Treated with a Combination Therapy of Anti-PD-1/-PD-L1 Antibodies and Platinum-Based Chemotherapy: A Multicenter Retrospective StudyTaro Hirabayashi, Kei Sonehara, Ryota Ozawa, et al.Cancer Medicine|August 3, 2024
Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective studyRyota Ozawa, Kei Sonehara, Tsutomu Hachiya, et al.Current Problems in Cancer|July 24, 2026
Multicenter retrospective study on the clinical profiles of patients with extensive-stage small-cell lung cancer who met the eligibility criteria for clinical trialsTatsuya Yazaki, Kei Sonehara, Toshiharu Tsutsui, et al.Thoracic Cancer|May 26, 2022
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapyTaisuke Araki, Kazunari Tateishi, Masamichi Komatsu, et al.Respiratory Investigation|July 27, 2025
Real-world data after introduction of chemoimmunotherapy in patients with extensive-disease small cell lung cancer: A multicenter retrospective studyTaro Hirabayashi, Kei Sonehara, Toshiharu Tsutsui, et al.Cancer Medicine|May 22, 2026
Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective StudyKei Sonehara, Toshiharu Tsutsui, Shuhei Nozawa, et al.Translational Lung Cancer Research|July 10, 2023
Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)Taisuke Araki, Shintaro Kanda, Masamichi Komatsu, et al.Pageof 4